Long-term GHRP-2 treatment maintained GH-releasing activity and body composition effects in GHRH knockout mice, proving GH secretagogues can function independently of the GHRH pathway for sustained benefit.
Key findingLong-term GHRP-2 treatment in GHRH knockout mice maintained GH secretion and body composition effects, demonstrating that GH secretagogues can sustain
What the researchers found
Long-term GHRP-2 treatment in GHRH knockout mice maintained GH secretion and body composition effects, demonstrating that GH secretagogues can sustainably stimulate GH through GHRH-independent pathways — important for conditions with GHRH deficiency.
Why it matters
Relevant for ghrp, hormone-optimization, receptor-signaling.
How the study worked
animal-study study on ghrp, hormone-optimization.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2005.
The bigger picture
Advances peptide/biomarker research with clinical implications.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Effects of long-term treatment with growth hormone-releasing peptide-2 in the GHRH knockout mouse.
American journal of physiology. Endocrinology and metabolism, 289(5), E762-7
Citation
Alba, Maria; Fintini, Danilo; Bowers, Cyril Y; Parlow, A F; Salvatori, Roberto. (2005). Effects of long-term treatment with growth hormone-releasing peptide-2 in the GHRH knockout mouse.. American journal of physiology. Endocrinology and metabolism, 289(5), E762-7.